For example, administration of both exogenous GLP-1 and GLP-1 receptor agonists has been shown to increase heart rate and attenuate the hypotensive response to an oral glucose or intraduodenal glucose infusion in both healthy subjects and patients with T2DM (3, 11–13). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.